Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
1.
Vet Dermatol ; 35(3): 354-359, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38247380

ABSTRACT

Proliferative, lymphocytic, infundibular mural folliculitis and dermatitis have been reported in six female Labrador retrievers from North America. This is the first report of the disease outside North America, describing the clinical and histopathological diagnosis and dermoscopic aspect of the verrucous plaques, treatment and co-morbidities in a female Labrador retriever dog.


La folliculite et la dermatite murale infundibulaire proliférative, lymphocytaire ont été rapportées chez six Labrador retrievers femelles d'Amérique du Nord. Il s'agit du premier rapport de cette affection en dehors de l'Amérique du Nord, décrivant le diagnostic clinique et histopathologique, l'aspect dermatoscopique des plaques verruqueuses, le traitement et les comorbidités chez une femelle Labrador retriever.


A foliculite e dermatite mural linfocítica infundibular proliferativa tem sido relatada em seis cadelas Labrador retriever da América do Norte. Este é o primeiro relato da doença fora da América do Norte, descrevendo o diagnóstico clínico e histopatológico e o aspecto dermoscópico de placas verrucosas, tratamento de comorbidades em uma cadela Labrador retriever.


Se ha publicado la descripción de una foliculitis y dermatitis mural infundibular, linfocítica y proliferativa en seis hembras de Labrador Retriever de América del Norte. Este es el primer informe de la enfermedad fuera de América del Norte, que describe el diagnóstico clínico e histopatológico y el aspecto dermatoscópico de las placas verrugosas, el tratamiento y las comorbilidades en una perra Labrador Retriever.


Subject(s)
Dermatitis , Dog Diseases , Folliculitis , Animals , Dogs , Folliculitis/veterinary , Folliculitis/pathology , Dog Diseases/pathology , Female , Dermatitis/veterinary , Dermatitis/pathology , Dermoscopy/veterinary , Apoptosis , Hair Follicle/pathology
2.
Vet Pathol ; 60(6): 876-887, 2023 11.
Article in English | MEDLINE | ID: mdl-37515544

ABSTRACT

Granulomatous mural folliculitis (GMF) is an uncommon reaction pattern occasionally observed in nonadapted ruminant hosts infected with malignant catarrhal fever viruses. This report characterizes GMF and concurrent cutaneous lesions in 16 goats with crusting dermatitis using histochemistry including hematoxylin and eosin, periodic acid-Schiff, and Grocott's methenamine silver, and immunohistochemistry for CD3, CD20, ionized calcium binding adaptor molecule 1, and cytokeratin AE1/3. Infiltrates in all 16 GMF cases consisted of macrophages and fewer T lymphocytes, and variably included eosinophils, multinucleated histiocytic giant cells, and/or neutrophils. Formalin-fixed paraffin-embedded skin and fresh skin samples from caprine GMF cases were tested using pan-herpesvirus nested conventional polymerase chain reaction (PCR) and partial sequencing, ovine herpesvirus-2 (OvHV-2) real-time PCR, and OvHV-2 colorimetric in situ hybridization (ISH). Five of 16 goats with GMF (31%) were PCR positive for malignant catarrhal fever viruses, including caprine herpesvirus 3 in 1 goat and OvHV-2 in 4 goats. Three goats also had positive intranuclear OvHV-2 hybridization signal in follicular keratinocytes, among other cell types, localized to areas of GMF. Herpesviruses were not detected in the formalin-fixed paraffin-embedded skin of 9 goats without GMF. This case series describes relatively frequent detections of malignant catarrhal fever viruses in the skin of goats with GMF, including the first report of caprine herpesvirus 3, and localizes OvHV-2 infected follicular keratinocytes within areas of GMF.


Subject(s)
Cattle Diseases , Folliculitis , Gammaherpesvirinae , Herpesviridae , Malignant Catarrh , Sheep Diseases , Cattle , Animals , Sheep , Goats , Glia Maturation Factor , Gammaherpesvirinae/genetics , Ruminants , Folliculitis/veterinary , Folliculitis/pathology , In Situ Hybridization/veterinary , Real-Time Polymerase Chain Reaction/veterinary , Formaldehyde
3.
Vet Pathol ; 60(6): 905-909, 2023 11.
Article in English | MEDLINE | ID: mdl-37313839

ABSTRACT

This report describes a unique pattern of alopecia in 8 American red squirrels (Tamiasciurus hudsonicus) from 2013 to 2021. All animals were juveniles; 6 were female and 2 were male. Seven presented between September and November, and one presented in April. All squirrels had widespread, bilaterally symmetric, noninflammatory, well-demarcated alopecia involving the entire trunk and legs and normal hair on their muzzle and dorsal surfaces of their paws. Six months later, a normal hair coat had grown on 2 of the animals, which were littermates. Hair fully grew 2 months later in another animal. Histopathology of the alopecic skin was performed in 7 of 8 animals. The following changes were noted: bent and coiled hairs, perforating folliculitis, melanin clumping, and distortion of hair shafts. Based on features of follicular dysplasia and apparent seasonality, this condition has some similarities to canine seasonal flank alopecia. A genetic etiology is suspected.


Subject(s)
Dog Diseases , Folliculitis , Rodent Diseases , Animals , Male , Female , Dogs , Alopecia/veterinary , Alopecia/pathology , Skin/pathology , Sciuridae , Folliculitis/pathology , Folliculitis/veterinary , Dog Diseases/pathology , Rodent Diseases/pathology
4.
J Am Vet Med Assoc ; 260(10): 1153-1156, 2022 05 04.
Article in English | MEDLINE | ID: mdl-35507517

ABSTRACT

Current guidelines for the use of systemic antimicrobials for the treatment of superficial bacterial folliculitis in dogs include the recommendation that the disease be treated for a minimum of 3 weeks and for at least 1 week beyond clinical resolution. With increasing antimicrobial resistance being noted for bacteria involved in this condition, as well as the increased use of evidence-based medicine, this dogma needs to be reevaluated.


Subject(s)
Anti-Infective Agents , Dog Diseases , Folliculitis , Prisoners , Dogs , Animals , Humans , Dog Diseases/drug therapy , Anti-Bacterial Agents/therapeutic use , Folliculitis/drug therapy , Folliculitis/microbiology , Folliculitis/veterinary , Anti-Infective Agents/therapeutic use
5.
Vet Dermatol ; 33(1): 36-e12, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34747076

ABSTRACT

BACKGROUND: Bathing with artificially carbonated water is reported to be a valuable therapeutic option for various human skin disorders. OBJECTIVE: To evaluate the clinical efficacy of artificially carbonated water bathing on superficial bacterial folliculitis (SBF) caused by Staphylococcus pseudintermedius (SP) in dogs. ANIMALS: Nineteen dogs with SBF from whom SP was isolated from skin lesions were enrolled. METHODS AND MATERIALS: Dogs with SBF were allocated randomly to either the artificially carbonated water bathing group or the control group bathed with tap water. The dogs were bathed with the designated water type on day (D)0, D7 and D14. Clinical scores and skin surface pH were evaluated on D0 and D21. Colony forming unit (cfu) assays were performed in vitro to investigate whether the artificially carbonated water affected growth of clinical SP isolates. RESULTS: The mean rate of improvement in the clinical scores was significantly higher in the carbonated water group than in the control group. Dogs bathed with carbonated water exhibited significant decreases in their skin surface pH after bathing; dogs bathed with tap water did not. No dogs experienced significant adverse events. The cfus of SP incubated in vitro with artificially carbonated water did not significantly differ from those incubated with tap water. CONCLUSION: Bathing with artificially carbonated water might be an effective and safe adjunctive therapy for canine SP-induced SBF.


Subject(s)
Carbonated Water , Dog Diseases , Folliculitis , Animals , Dog Diseases/therapy , Dogs , Folliculitis/therapy , Folliculitis/veterinary , Skin , Treatment Outcome
6.
Vet Dermatol ; 32(4): 389-e111, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34033160

ABSTRACT

Erythema multiforme is a rare hypersensitivity reaction that is reported in several domestic animal species, and not in goats. This case report describes the clinical and histopathological features of erythema multiforme and secondary bacterial skin infection in a goat.


Un érythème polymorphe est une réaction d 'hypersensibilité rare décrite chez plusieurs espèces d'animaux domestiques mais pas chez la chèvre. Cet article décrit les données cliniques et histopathologiques d'un érythème polymorphe et d'une infection bactérienne secondaire chez une chèvre.


El eritema multiforme es una reacción de hipersensibilidad rara que se ha descrito en diversas especies de animales domésticos, pero no en cabras. Este artículo describe las características clínicas e histopatológicas de eritema multiforme e infección cutánea bacteriana secundaria en una cabra.


O eritema multiforme é uma reação de hipersensibilidade rara relatada em várias espécies de animais domésticos, e não em cabras. Este relato de caso descreve as características clínicas e histopatológicas de eritema multiforme e infecção bacteriana secundária da pele em uma cabra.


Subject(s)
Erythema Multiforme , Folliculitis , Goat Diseases , Skin Diseases, Bacterial , Animals , Erythema Multiforme/diagnosis , Erythema Multiforme/veterinary , Folliculitis/diagnosis , Folliculitis/veterinary , Goat Diseases/diagnosis , Goats , Skin Diseases, Bacterial/veterinary
8.
Vet Dermatol ; 31(2): 170-174, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31908101

ABSTRACT

BACKGROUND: Canine granulomatous mural folliculitis is a very rare cause of scarring alopecia with unknown pathogenesis. HYPOTHESIS/OBJECTIVES: To report a case of granulomatous mural folliculitis in a dog treated with ciclosporin (Cs) and methotrexate (MTX). ANIMAL: A 13-year-old spayed female Pyrenean shepherd dog with a one month history of scarring alopecia. METHODS AND RESULTS: Histopathological examination revealed a granulomatous and lymphocytic mural and necrotizing folliculitis and furunculosis. Immunochemistry, using antibodies for CD3, CD204, CD206, IBA-1 and CD208, revealed that CD3+ lymphocytes were infiltrating the outer root sheath along with IBA-1+ or CD204+ cells. Ciclosporin (5 mg/kg once daily) and MTX (0.25 mg/kg once weekly then 0.5 mg/kg once weekly) were initiated simultaneously, and Cs was stopped after stabilization of the lesions. The dog's skin disease was stable for six months. CONCLUSIONS AND CLINICAL IMPORTANCE: To the best of the authors' knowledge, this is the first report of the long-term management of a granulomatous mural folliculitis in a dog. Ciclosporin and MTX appeared to be an effective treatment option. Additional treated cases are needed to assess the effectiveness of MTX in canine immune-mediated diseases.


Subject(s)
Alopecia/veterinary , Cyclosporine/therapeutic use , Folliculitis/veterinary , Methotrexate/therapeutic use , Skin Diseases/veterinary , Alopecia/complications , Animals , Disease Management , Dog Diseases/drug therapy , Dogs , Female , Folliculitis/diagnosis , Histological Techniques , Inflammation , Skin/drug effects , Skin Diseases/drug therapy
9.
Pesqui. vet. bras ; 38(12): 2233-2236, dez. 2018. tab
Article in English | LILACS, VETINDEX | ID: biblio-976423

ABSTRACT

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) being a constant concern, ceftaroline fosamil has been recently approved as a new cephalosporin, active against MRSA, for use in humans; only rare cases of resistance have been reported till date. There is no report of resistance to ceftaroline in Staphylococcus pseudintermedius, which is the main bacterium causing dermatitis and otitis in dogs. To evaluate staphylococcal resistance to ceftaroline, 35 isolates of methicillin-resistant S. pseudintermedius (MRSP), carrying the mecA gene, from 26 dogs with folliculitis and nine dogs with external otitis, underwent disk diffusion test with cefoxitin, oxacillin, and ceftaroline. Tests with cefoxitin and oxacillin showed > 90% sensitivity in methicillin resistance detection. In the disk diffusion test, 97.14% (34/35) were resistant to cefoxitin, 94.29% (33/35) to oxacillin, and 31.43% (11/35) to ceftaroline. Of the ceftaroline-resistant strains, 27.27% (3/11) were obtained from the ears of dogs while the rest (8/11) were from the skin. The current report is the first description of MRSP resistance to ceftaroline.(AU)


Infecções causadas por Staphylococcus aureus resistente à meticilina (MRSA) são uma preocupação médica constante. A ceftarolina fosamila é uma nova cefalosporina ativa contra Staphylococcus aureus resistente à meticilina recentemente aprovada para uso em humanos e raros casos de resistência relatados até agora. Não há relatos de resistência à ceftarolina em Staphylococcus pseudintermedius, principal bactéria causadora de dermatite e otite em cães. Com o objetivo de avaliar a resistência estafilocócica à ceftarolina, 35 amostras de S. pseudintermedius resistentes à meticilina (MRSP), portadoras do gene mecA, provenientes de 26 cães com foliculite e 9 com otite externa foram submetidos ao teste de disco-difusão com cefoxitina, oxacilina e ceftarolina. Os testes realizados com cefoxitina e oxacilina mostraram mais de 90% de sensibilidade na detecção da resistência à meticilina em ambas. No teste da disco-difusão, 97,14% (1/35) foram resistentes à cefoxitina, 94,29% (3/35) à oxacilina e 31,43% (11/35) à ceftarolina. Das cepas resistentes às ceftarolina, 27,27 (3/11) foram provenientes de ouvido de cães e as demais (8/11), provenientes da pele, sendo essa primeira descrição de resistência de MRSP à ceftarolina na literatura atual.(AU)


Subject(s)
Animals , Dogs , Oxacillin , Staphylococcus/genetics , Staphylococcus aureus , Staphylococcal Skin Infections/veterinary , Cefoxitin , Cephalosporin Resistance , Dogs/microbiology , Dermatitis/veterinary , Disk Diffusion Antimicrobial Tests/veterinary , Folliculitis/veterinary
10.
Vet Pathol ; 55(5): 731-735, 2018 09.
Article in English | MEDLINE | ID: mdl-29661122

ABSTRACT

A striking form of lymphocytic mural folliculitis is described in 6 tigers ( Panthera tigris). Clinically, all tigers exhibited regionally extensive chronic, variably waxing and waning alopecia with minimal scaling and crusting most pronounced over the head, neck, and shoulders. More severely affected tigers exhibited marked hyperpigmentation and lichenification. Pruritus was not a feature. Tigers generally lacked signs of systemic illness and clinical pathology findings were unremarkable. Histologic examination of skin biopsies revealed infiltrative lymphocytic mural folliculitis extending the length of the hair follicle. Mild epidermal lymphocytic infiltrates were frequent. The surrounding dermis was histologically unremarkable in 4 of 6 tigers or associated with mild perifollicular and periadnexal mixed inflammation in 2 of 6 tigers. The cause of the mural folliculitis was not identified, and tigers responded poorly to immunomodulatory therapy. Lymphocytic mural folliculitis might be a nonspecific hypersensitivity reaction pattern in tigers, and care should be taken to differentiate this reaction pattern from epitheliotropic T-cell lymphoma.


Subject(s)
Folliculitis/veterinary , Lymphoma/veterinary , Tigers , Animals , Diagnosis, Differential , Folliculitis/diagnosis , Folliculitis/pathology , Lymphocytes/pathology , Lymphoma/diagnosis , Lymphoma/pathology , Skin/pathology
12.
Vet Dermatol ; 27(1): 57-e18, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26707941

ABSTRACT

OBJECTIVE: To describe a case of feline sebaceous adenitis and mural folliculitis, and its successful treatment with topical fatty acids. ANIMAL: A 5-year-old, male castrated Norwegian Forest cat was presented with a progressive seborrhoeic dermatitis. METHODS: Clinical examination and histopathological examination of skin biopsies. RESULTS: There was severe, multifocal, lymphocytic mural folliculitis and perifollicular dermatitis, moderate hyperkeratosis and sebaceous adenitis on histopathology. Sebaceous glands were either absent or almost completely effaced by a dense lymphocytic infiltrate. Clinical signs began in spring on the face and neck and progressed over an 18 month period to involve the legs. Initially, topical and systemic antibacterial therapy for a mild bacterial overgrowth resulted in partial clinical response. There was no improvement with oral omega 6 fatty acids and surface cleaning. Treatment with a spot-on product containing essential oils, smoothing agents and vitamin E as the sole therapy was associated with a good--but incomplete--clinical response over a 6 month period, with hair regrowth and a marked decrease in seborrhoeic dermatitis. This improvement was sustained until 12 months later when a severe deep pyoderma with associated anorexia and depression occurred. This was symptomatically treated and the cat remained clinically stable for a further 18 months. Periocular and perinasal seborrhoea was a persistent feature. CONCLUSION AND CLINICAL IMPORTANCE: Topical essential fatty acid therapy may offer a viable alternative to ciclosporin, which has been reported for the successful treatment of this rare disease in cats.


Subject(s)
Cat Diseases/drug therapy , Fatty Acids/therapeutic use , Folliculitis/veterinary , Lymphadenitis/veterinary , Administration, Topical , Animals , Cat Diseases/pathology , Cats , Folliculitis/drug therapy , Folliculitis/pathology , Lymphadenitis/drug therapy , Lymphadenitis/pathology , Male
13.
J Feline Med Surg ; 17(6): 548-50, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25406176

ABSTRACT

A 9-year-old castrated domestic shorthair cat was presented with a 6 week history of progressive non-pruritic alopecia, polyphagia and weight loss. A diagnosis of lymphocytic mural folliculitis was made and the cat was treated with a combination of prednisolone and ciclosporin; this produced an improvement in the alopecia but no resolution. Sixteen months after the initial assessment and diagnosis, the cat was re-evaluated for intermittent vomiting and weight loss with normal appetite. On examination the dermatopathy was still evident and a mass involving the duodenum and pancreas was present, which was diagnosed as a pancreatic carcinoma. From this case it would appear that lymphocytic mural folliculitis might be an early dermatological manifestation of pancreatic neoplasia.


Subject(s)
Alopecia/veterinary , Cat Diseases/pathology , Cat Diseases/surgery , Dermatitis/veterinary , Folliculitis/veterinary , Pancreatic Neoplasms/veterinary , Alopecia/etiology , Animals , Cats , Dermatitis/etiology , Folliculitis/etiology , Male , Pancreatectomy/veterinary , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms
16.
Vet Dermatol ; 25(3): 163-e43, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24720433

ABSTRACT

BACKGROUND: Superficial bacterial folliculitis (SBF) is usually caused by Staphylococcus pseudintermedius and routinely treated with systemic antimicrobial agents. Infection is a consequence of reduced immunity associated with alterations of the skin barrier and underlying diseases that may be difficult to diagnose and resolve; thus, SBF is frequently recurrent and repeated treatment is necessary. The emergence of multiresistant bacteria, particularly meticillin-resistant S. pseudintermedius (MRSP), has focused attention on the need for optimal management of SBF. OBJECTIVES: Provision of an internationally available resource guiding practitioners in the diagnosis, treatment and prevention of SBF. DEVELOPMENT OF THE GUIDELINES: The guidelines were developed by the Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases, with consultation and advice from diplomates of the American and European Colleges of Veterinary Dermatology. They describe optimal methods for the diagnosis and management of SBF, including isolation of the causative organism, antimicrobial susceptibility testing, selection of antimicrobial drugs, therapeutic protocols and advice on infection control. Guidance is given for topical and systemic modalities, including approaches suitable for MRSP. Systemic drugs are classified in three tiers. Tier one drugs are used when diagnosis is clear cut and risk factors for antimicrobial drug resistance are not present. Otherwise, tier two drugs are used and antimicrobial susceptibility tests are mandatory. Tier three includes drugs reserved for highly resistant infections; their use is strongly discouraged and, when necessary, they should be used in consultation with specialists. CONCLUSIONS AND CLINICAL IMPORTANCE: Optimal management of SBF will improve antimicrobial use and reduce selection of MRSP and other multidrug-resistant bacteria affecting animal and human health.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Dog Diseases/diagnosis , Folliculitis/veterinary , Skin Diseases, Bacterial/veterinary , Animals , Anti-Bacterial Agents/administration & dosage , Dog Diseases/drug therapy , Dogs , Folliculitis/diagnosis , Folliculitis/drug therapy , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy
17.
J Feline Med Surg ; 16(6): 527-31, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24101746

ABSTRACT

An 11-year-old spayed female domestic shorthair cat was presented for polydipsia, hyperactivity and bilateral thyroid gland enlargement. Total T4 (TT4) was in the upper interval range; therefore, an early hyperthyroidism was suspected. A treatment trial with methimazole was started, as the owner refused further tests. Six months later the owner stopped the treatment. One year later, clinical signs persisted and TT4 was still in the upper interval range. Methimazole was re-introduced but 48 h later the cat presented non-pruritic alopecia with erythema, scales and perilesional yellowish crusts. Pyogranulomatous mural folliculitis was diagnosed by histopatological examination of the skin biopsies. Methimazole was withdrawn and macroscopic lesions healed and disappeared histologically in 15 days. An idiosyncratic drug reaction to methimazole was suspected. To the best of our knowledge, this is the first report of feline pyogranulomatous mural folliculitis likely secondary to an adverse drug reaction to methimazole administration.


Subject(s)
Antithyroid Agents/adverse effects , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Folliculitis/veterinary , Hyperthyroidism/veterinary , Methimazole/adverse effects , Animals , Antithyroid Agents/therapeutic use , Cats , Female , Folliculitis/chemically induced , Hyperthyroidism/drug therapy , Methimazole/therapeutic use , Thyroid Function Tests
18.
Vet J ; 199(2): 217-22, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24345778

ABSTRACT

Superficial bacterial folliculitis (SBF) is more common in the dog than other mammalian species. Until recently, a successful outcome in cases of canine SBF was possible by administering a potentiated amoxicillin, a first generation cephalosporin or a potentiated sulfonamide. Unfortunately, this predictable susceptibility has changed, because methicillin resistant Staphylococcus pseudintermedius (MRSP) and Staphylococcus aureus (MRSA) are becoming more prevalent in canine SBF cases. The increasing frequency of multidrug resistance complicates the selection of antimicrobial therapy. Antimicrobial agents that were once rarely used in cases of canine SBF, such as amikacin, rifampicin and chloramphenicol, are becoming the drugs of choice, based on bacterial culture and susceptibility testing. Furthermore, changes in antimicrobial susceptibility have helped to re-emphasize the importance of a multimodal approach to treatment of the disease, including topical therapy. Due to the increasing frequency of identification of highly resistant Staphylococcus spp., topical antimicrobial therapy, including the use of diluted sodium hypochlorite (bleach), is becoming necessary to successfully treat some cases of canine SBF. Other important antiseptics that can be used include chlorhexidine, benzoyl peroxide, ethyl lactate, triclosan and boric acid/acetic acid. This review discusses the diagnostic and therapeutic management of canine SBF, with a special emphasis on treating methicillin resistant staphylococcal infections.


Subject(s)
Bacterial Infections/veterinary , Dog Diseases , Folliculitis/veterinary , Administration, Topical , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/diagnosis , Bacterial Infections/drug therapy , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Dog Diseases/microbiology , Dogs , Drug Resistance, Microbial , Folliculitis/drug therapy , Folliculitis/microbiology , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus , Microbial Sensitivity Tests , Staphylococcal Skin Infections/drug therapy , Staphylococcal Skin Infections/microbiology , Staphylococcal Skin Infections/veterinary , Staphylococcus/drug effects , Staphylococcus intermedius
19.
Vet Clin North Am Equine Pract ; 29(3): 559-75, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24267675

ABSTRACT

Bacterial, dermatophilosis, and superficial ringworm infections are common skin diseases noted in equine dermatology. The ability to recognize and accurately diagnose the skin condition is key to selecting an appropriate and successful treatment regimen. Addressing underlying etiology, environmental management, and infection control play a crucial role in preventing relapse of clinical signs.


Subject(s)
Folliculitis/veterinary , Horse Diseases/diagnosis , Horse Diseases/therapy , Tinea/veterinary , Animals , Anti-Bacterial Agents/therapeutic use , Folliculitis/diagnosis , Folliculitis/microbiology , Folliculitis/therapy , Horse Diseases/microbiology , Horses , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/diagnosis , Staphylococcal Infections/therapy , Staphylococcal Infections/veterinary , Tinea/diagnosis , Tinea/microbiology , Tinea/therapy
20.
Vet Dermatol ; 24(3): 346-54, e76-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23600606

ABSTRACT

OBJECTIVES: To describe the clinical, histopathological and immunohistochemical lesions and the response to therapy of a novel skin disease in four dogs, and to compare the lesions with those of other similar conditions. METHODS: Clinical lesions, the histopathological findings in skin biopsy samples, immunohistochemistry for CD3 and cleaved caspase-3 and the response to therapy were evaluated. RESULTS: Clinical lesions included multifocal, coalescing, verrucous, crusted papules and plaques with erythematous borders and comedones or follicular casts. Lesions were in haired skin; they occurred at the edges of paw pads and claw beds in one dog. Histopathological lesions included ortho- and more prominent parakeratotic hyperkeratosis involving follicular infundibular epithelium, with cast formation and a papillary epidermal surface. Lymphocytic exocytosis affected all strata of follicular infundibular epithelium and epidermis. Variable numbers of acidophilic shrunken keratinocytes, often bordered by lymphocytes (satellitosis), occupied the more superficial strata of the follicular infundibular epithelium and epidermis. Immunohistochemistry revealed numerous CD3+ T lymphocytes and fewer cleaved caspase-3-positive apoptotic keratinocytes in the infundibular hair follicle epithelium and epidermis, with numerous CD3+ T lymphocytes and cleaved caspase-3-positive cells in the dermis. Two dogs responded completely to therapy with ciclosporin and remained lesion free off therapy; one dog responded to therapy with prednisone, azathioprine and ciclosporin, but relapsed; and one dog was not treated. CONCLUSIONS AND CLINICAL IMPORTANCE: The cause of the lesions is unknown; the presence of intraepithelial CD3+ lymphocytes and cleaved caspase-3-positive apoptotic keratinocytes and the positive response to immunosuppressive therapy suggest an immune response directed towards unidentified antigens expressed on the surface of keratinocytes.


Subject(s)
Apoptosis/physiology , Dermatitis/veterinary , Dog Diseases/pathology , Folliculitis/veterinary , Immunosuppressive Agents/therapeutic use , Animals , Dermatitis/drug therapy , Dermatitis/pathology , Dog Diseases/drug therapy , Dogs , Female , Folliculitis/drug therapy , Folliculitis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...